Mirae Asset Global Investments’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.6K Sell
3,970
-569
-13% -$5.37K ﹤0.01% 1374
2026
Q1
$36.9K Buy
4,539
+311
+7% +$2.67K ﹤0.01% 1347
2025
Q4
$43.9K Buy
4,228
+872
+26% +$9.15K ﹤0.01% 1422
2025
Q3
$29.7K Buy
3,356
+12
+0.4% +$86 ﹤0.01% 1434
2025
Q2
$19.3K Buy
3,344
+642
+24% +$3.93K ﹤0.01% 1403
2025
Q1
$19K Buy
2,702
+111
+4% +$865 ﹤0.01% 1392
2024
Q4
$22.5K Sell
2,591
-181
-7% -$2.6K ﹤0.01% 1405
2024
Q3
$54.1K Buy
2,772
+498
+22% +$10.1K ﹤0.01% 1289
2024
Q2
$46.6K Sell
2,274
-38,696
-94% -$795K ﹤0.01% 1262
2024
Q1
$611K Buy
40,970
+4,659
+13% +$90.6K ﹤0.01% 1814
2023
Q4
$522K Sell
36,311
-2,207
-6% -$21.7K ﹤0.01% 1944
2023
Q3
$351K Buy
38,518
+905
+2% +$9.19K ﹤0.01% 2064
2023
Q2
$396K Sell
37,613
-3,783
-9% -$44.7K ﹤0.01% 2049
2023
Q1
$506K Buy
41,396
+10,362
+33% +$129K ﹤0.01% 1918
2022
Q4
$385K Buy
31,034
+3,301
+12% +$48K ﹤0.01% 2030
2022
Q3
$379K Buy
27,733
+8,129
+41% +$125K ﹤0.01% 2037
2022
Q2
$359K Buy
+19,604
New +$282K ﹤0.01% 1901

Other funds holding KURA

Mirae Asset Global Investments's KURA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Kura Oncology (KURA) stake by 13% in Q2 2026, selling an estimated $5.37K and leaving 3,970 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Mirae Asset Global Investments first reported a position in KURA in Q2 2022 and has held it in 17 quarters since. The position peaked at $611K in Q1 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Mirae Asset Global Investments held 3,970 shares of Kura Oncology worth $43.6K as of Q2 2026.
  • Mirae Asset Global Investments sold 569 Kura Oncology shares in Q2 2026, an estimated $5.37K.
  • Kura Oncology made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1374 holding.
  • Mirae Asset Global Investments first reported a position in Kura Oncology in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Kura Oncology position peaked at $611K in Q1 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.